Date: 2015-02-27
Type of information: Distribution agreement
Compound: human health products for use in clinical trials
Company: Clinigen (UK) Merck&Co (USA - NJ)
Therapeutic area:
Type agreement: distribution
Action mechanism:
Disease:
Details: * On February 27, 2015, Clinigen Group announced that its Clinical Trials Supply business (Clinigen CTS) has entered into an agreement with Merck Sharp & Dohme, to distribute their human health products for use in clinical trials carried out in Europe. This agreement now represents the fourth arrangement Clinigen CTS has with manufacturers to distribute products.
Under the terms of the agreement, Clinigen CTS will be a preferred distributor and manage enquiries, order receipts and distribution of MSD’s products to manufacturers, contract research organizations (CROs), clinical trial contract packagers and other specialist service providers looking to source pharmaceutical products as comparators, rescue and adjunctive drugs for use in clinical trials.
Financial terms:
Latest news:
